Abstract:Background: Progressive difficulty in performing everyday functional activities is a key diagnostic feature of dementia syndromes. However, not much is known about the neural signature of functional decline, particularly during the very early stages of dementia. Early intervention before overt impairment is observed offers the best hope of reducing the burdens of Alzheimer disease (AD) and other dementias. However, to justify early intervention, those at risk need to be detected earlier and more accurately. The decline in complex daily function (CdF) such as managing medications has been reported to precede impairment in basic activities of daily living (eg, eating and dressing). Objective: Our goal is to establish the neural signature of decline in CdF during the preclinical dementia period. Methods: Gait is central to many CdF and community-based activities. Hence, to elucidate the neural signature of CdF, we validated a novel electroencephalographic approach to measuring gait-related brain activation while participants perform complex gait-based functional tasks. We hypothesize that dementia-related pathology during the preclinical period activates a unique gait-related electroencephalographic (grEEG) pattern that predicts a subsequent decline in CdF. Results: We provide preliminary findings showing that older adults reporting CdF limitations can be characterized by a unique gait-related neural signature: weaker sensorimotor and stronger motor control activation. This subsample also had smaller brain volume and white matter hyperintensities in regions affected early by dementia and engaged in less physical exercise. We propose a prospective observational cohort study in cognitively unimpaired older adults with and without subclinical AD (plasma amyloid-β) and vascular (white matter hyperintensities) pathologies. We aim to (1) establish the unique grEEG activation as the neural signature and predictor of decline in CdF during the preclinical dementia period; (2) determine associations between dementia-related pathologies and incidence of the neural signature of CdF; and (3) establish associations between a dementia risk factor, physical inactivity, and the neural signature of CdF. Conclusions: By establishing the clinical relevance and biological basis of the neural signature of CdF decline, we aim to improve prediction during the preclinical stages of ADs and other dementias. Our approach has important research and translational implications because grEEG protocols are relatively inexpensive and portable, and predicting CdF decline may have real-world benefits. International registered report identifier (irrid): DERR1-10.2196/56726.

Cerebral networks of apathy and goal-oriented patterns of actimetry in late-life depression

Quantifying Apathy in Late-Life Depression: Unraveling Neurobehavioral Links through Daily Activity Patterns and Brain Connectivity Analysis

Data-driven Approaches to Executive Function Performance and Structure in Aging: Integrating Person-Centered Analyses and Machine Learning Risk Prediction.

Microstructural brain assessment in late-life depression and apathy using diffusion MRI multi-compartments models and tractometry

Individualized prediction of cognitive test scores from functional brain connectome in patients with first-episode late-life depression

Cognitive signatures of depressive and anhedonic symptoms, and affective states, using computational modeling and neurocognitive testing

Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment

Brain morphometric features predict depression symptom phenotypes in late-life depression using a deep learning model

Machine Learning Prediction of Treatment Outcome in Late-Life Depression

Brain-based mechanisms of late-life depression: Implications for novel interventions

Machine learning identifies novel markers predicting functional decline in older adults

Identifying a Common Functional Framework for Apathy Large-Scale Brain Network

Linking Dementia Pathology and Alteration in Brain Activation to Complex Daily Functional Decline During the Preclinical Dementia Stages: Protocol for a Prospective Observational Cohort Study

Influences of resting-state intrinsic functional brain connectivity on the antidepressant treatment response in late-life depression

Neural Functioning in Late-Life Depression: An Activation Likelihood Estimation Meta-Analysis

Intrinsic Inter-Network Brain Dysfunction Correlates with Symptom Dimensions in Late-Life Depression

Contribution of neuroimaging in late-life depression

Intra-network and Inter-Network Shared Connectivity Patterns in Patients with Remitted Late-Life Depression and Amnestic Mild Cognitive Impairment

A shared cognitive and neural basis underpinning cognitive apathy and planning in behavioural-variant frontotemporal dementia and Alzheimer's disease

Automatic diagnosis of late-life depression by 3D convolutional neural networks and cross-sample Entropy analysis from resting-state fMRI

A novel biomarker selection method using multimodal neuroimaging data